Parian Global Management’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
Other funds holding TOI
DM
RG
VCIM
TM
SCM
Parian Global Management's TOI Position: Q3 2022 in Review
Parian Global Management increased its The Oncology Institute (TOI) stake by 31% in Q3 2022, buying an estimated $335K and bringing the position to 240,724 shares worth $1.11M. The position accounts for 3.63% of the portfolio, ranked #9.
Parian Global Management first reported a position in TOI in Q4 2021 and has held it in 4 quarters since. The position peaked at $4.55M in Q4 2021. 39 funds tracked by Wall St. Rank hold TOI as of Q3 2022.
- Parian Global Management held 240,724 shares of The Oncology Institute worth $1.11M as of Q3 2022.
- Parian Global Management bought 56,896 The Oncology Institute shares in Q3 2022, an estimated $335K.
- The Oncology Institute made up 3.63% of Parian Global Management's portfolio in Q3 2022, its #9 holding.
- Parian Global Management first reported a position in The Oncology Institute in Q4 2021 and has held it in 4 quarters since.
- Parian Global Management's The Oncology Institute position peaked at $4.55M in Q4 2021.
- 39 funds tracked by Wall St. Rank held The Oncology Institute as of Q3 2022.
Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.